COL-VAC

Serial Number 78397619
606

Registration Progress

Application Filed
Apr 7, 2004
Under Examination
Dec 20, 2005
Approved for Publication
Sep 7, 2005
Published for Opposition
Sep 27, 2005
Registered

Trademark Image

COL-VAC

Basic Information

Serial Number
78397619
Filing Date
April 7, 2004
Published for Opposition
September 27, 2005
Abandonment Date
December 21, 2006
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 21, 2006
Classes
005

Rights Holder

Celldex Therapeutics, Inc.

03
Address
519 Route 173 West
Bloomsbury, NJ 08804

Ownership History

Celldex Therapeutics, Inc.

Original Applicant
03
Bloomsbury, NJ

Celldex Therapeutics, Inc.

Owner at Publication
03
Bloomsbury, NJ

Legal Representation

Attorney
Mark Lerner

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

18 events
Date Code Type Description Documents
Feb 27, 2007 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Feb 27, 2007 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 20, 2006 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 20, 2006 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 20, 2006 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 20, 2005 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 27, 2005 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 7, 2005 NPUB O NOTICE OF PUBLICATION Loading...
Jun 6, 2005 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jun 3, 2005 ALIE A ASSIGNED TO LIE Loading...
May 31, 2005 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 4, 2005 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 29, 2005 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 29, 2005 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 29, 2004 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 29, 2004 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 29, 2004 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 15, 2004 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Vaccines, therapeutic vaccines and therapeutic pharmaceuticals derived from monoclonal antibodies for use in the treatment of cancer
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
COL-VACCINES

Classification

International Classes
005